- Glucosidase inhibitors ( - GIs ) , which reduce post-prandial hyperglycemia without stimulating insulin secretion , significantly reduce the risk of coronary artery disease ( CAD ) , whereas glinides , which improve post-prandial hyperglycemia through post-prandial insulin secretion , do not appear to affect CAD .